[Treatment with Miltex for metastatic skin lesions in breast cancer] . / Primenenie Milteksa dlia lecheniia metastaticheskikh porazhenii kozhi pri rake molochnoi zhelezy.

Miltex (miltefosine) is a new antiproliferation drug comprising phospholipid ingredients. It is used for topical treatment of metastatic skin lesions in breast cancer. Clinical trials of the drug were conducted in 11 breast cancer patients resistant to standard therapy. Apparent therapeutic effect (partial regression) was registered in 27.3% (3/11). Moderate toxic effects were generally confined to skin itching (36.4%) and scaling (18.2%), erythema (18.2%), and paper skin (45.5%).